China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)
China flag China · Delayed Price · Currency is CNY
17.47
-0.38 (-2.13%)
May 12, 2026, 3:04 PM CST

SHE:300294 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
821.74573.741,3001,9611,5321,584
Short-Term Investments
108.97108.14----
Trading Asset Securities
1,9462,5492,1993,3623,1942,700
Cash & Short-Term Investments
2,8763,2313,4995,3244,7264,284
Cash Growth
-14.09%-7.67%-34.28%12.66%10.31%468.21%
Accounts Receivable
886.83919.69509.38275.92567.02588.08
Other Receivables
56.5649.1739.81264.4100.6267.9
Receivables
943.39968.86549.19540.32667.64655.98
Inventory
1,029996.2995.43556.94666.96676.84
Other Current Assets
105.1337.8914.756.4313.2529.4
Total Current Assets
4,9545,2345,0586,4286,0735,646
Property, Plant & Equipment
1,6531,6511,170676.62722.81771.33
Long-Term Investments
148.68356.41407.51100.39117.09144.96
Goodwill
617.53617.5372872.61663.84663.84
Other Intangible Assets
494.66495.56773.28269.31312.17169.47
Long-Term Deferred Tax Assets
81.5683.2373.5447.3444.9927.44
Long-Term Deferred Charges
144.58145.29145.988.1582.64161.62
Other Long-Term Assets
311.3943.8444.38146.8316.2437.2
Total Assets
8,4068,6268,4017,8298,0337,622
Accounts Payable
290.54507.51357.62126.35303.46277.53
Accrued Expenses
75.47421.14323.81274.14290.9261.19
Current Portion of Long-Term Debt
---0.0322.180.08
Current Portion of Leases
5.735.795.330.872.812.06
Current Income Taxes Payable
15.482.0812.448.5827.0941.45
Current Unearned Revenue
15.468.124.0812.2120.5812.97
Other Current Liabilities
381.8489.1647.0934.2638.3335.66
Total Current Liabilities
784.511,034750.38456.45705.34630.94
Long-Term Debt
58.3147.07-22.15-22.15
Long-Term Leases
11.2212.737.171.410.3711.3
Long-Term Unearned Revenue
24.2725.3919.5123.5227.0930.98
Long-Term Deferred Tax Liabilities
64.568136.324.565.565.94
Total Liabilities
942.81,187913.38508.07748.35701.3
Common Stock
504.25504.25504.25504.25504.25511.63
Additional Paid-In Capital
4,0634,0634,0634,0634,0654,258
Retained Earnings
2,9042,8742,9182,7532,6162,259
Treasury Stock
------199.96
Comprehensive Income & Other
-9.47-3.522.36---
Total Common Equity
7,4627,4387,4877,3207,1866,829
Minority Interest
1.361.550.611.0799.1991.4
Shareholders' Equity
7,4637,4397,4887,3217,2856,920
Total Liabilities & Equity
8,4068,6268,4017,8298,0337,622
Total Debt
75.2665.5912.5124.4535.3635.58
Net Cash (Debt)
2,8013,1653,4865,2994,6904,248
Net Cash Growth
-16.05%-9.22%-34.21%12.99%10.41%903.09%
Net Cash Per Share
5.456.186.9410.499.339.74
Filing Date Shares Outstanding
504.25504.25504.25504.25504.25504.25
Total Common Shares Outstanding
504.25504.25504.25504.25504.25504.25
Working Capital
4,1704,2004,3085,9715,3685,015
Book Value Per Share
14.8014.7514.8514.5214.2513.54
Tangible Book Value
6,3506,3255,9866,9786,2105,996
Tangible Book Value Per Share
12.5912.5411.8713.8412.3111.89
Buildings
-655.73741.4527.95518.01536.62
Machinery
-715.37839.25625.83671.97665.73
Construction In Progress
-938.5732139.9469.3440.86
Source: S&P Global Market Intelligence. Standard template. Financial Sources.